Raha Samraat S. bought MYGN
June 11, 2026 · Form 4 insider transaction
Raha Samraat S. bought 3,542 shares of Myriad Genetics, Inc. at $3.94 per share, a transaction worth $13.9K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,542
Price
$3.94
Total value
$13.9K
InsiderRaha Samraat S.
Role—
CompanyMyriad Genetics, Inc. (MYGN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 11, 2026
Filing dateJune 12, 2026
Shares owned after1,068,083
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were acquired under the Issuer's Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).